These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs). Stepanova D; Beran RG Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809 [TBL] [Abstract][Full Text] [Related]
23. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets. Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473 [TBL] [Abstract][Full Text] [Related]
24. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Vajda FJ; O'Brien T; Lander C; Graham J; Eadie M Epilepsia; 2014 Aug; 55(8):1229-34. PubMed ID: 24995555 [TBL] [Abstract][Full Text] [Related]
31. Low-dose levetiracetam for seizure prophylaxis after traumatic brain injury. Patanwala AE; Kurita A; Truong E Brain Inj; 2016; 30(2):156-8. PubMed ID: 26619246 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
33. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy. Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041 [TBL] [Abstract][Full Text] [Related]
34. Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers. Lins RL; Otoul C; De Smedt F; Coupez R; Stockis A Int J Clin Pharmacol Ther; 2007 Jan; 45(1):47-54. PubMed ID: 17256450 [TBL] [Abstract][Full Text] [Related]
35. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Ylikotila P; Ketola RA; Timonen S; Malm H; Ruuskanen JO Reprod Toxicol; 2015 Nov; 57():204-6. PubMed ID: 26187779 [TBL] [Abstract][Full Text] [Related]
36. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy. Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893 [TBL] [Abstract][Full Text] [Related]
37. Seizures in patients with glioma treated with phenytoin and levetiracetam. Merrell RT; Anderson SK; Meyer FB; Lachance DH J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals. MacDonald KD; Hart KA; Davis JL; Berghaus LJ; Giguère S Equine Vet J; 2018 Jul; 50(4):532-536. PubMed ID: 29194744 [TBL] [Abstract][Full Text] [Related]
39. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring. Matar KM J Pharm Biomed Anal; 2008 Nov; 48(3):822-8. PubMed ID: 18603399 [TBL] [Abstract][Full Text] [Related]
40. Development of tolerance to levetiracetam in rats with chronic epilepsy. van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]